Companies
Cyclopure
commercializes DEXSORB, a molecularly-imprinted cyclodextrin polymer sold as a flow-through cartridge for combined PFAS and microplastic capture, marketed to both residential and commercial/municipal customers; DEXSORB received Massachusetts state approval for PFAS treatment in 2026.
- Country
- United States
Microplastic + PFAS removal
Coverage
| EU | US | |
|---|---|---|
| bioremediation | ✓ | ✓ |
Regulatorsepareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio-microplastic filtration from wastewater | bioremediation | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.